Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies

PURPOSE: Duloxetine (DLX) is dual serotonin and norepinephrine reuptake inhibitor suffering from limited bioavailability (≈ 40%) due to extensive hepatic metabolism. This work aims to formulate and evaluate DLX intranasal thermoreversible cubosomal gels to enhance its bioavailability and ensure effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsenosy, Fatma Mohamed, Abdelbary, Ghada Ahmed, Elshafeey, Ahmed Hassen, Elsayed, Ibrahim, Fares, Ahmed Roshdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732760/
https://www.ncbi.nlm.nih.gov/pubmed/33324051
http://dx.doi.org/10.2147/IJN.S277352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732760/
https://www.ncbi.nlm.nih.gov/pubmed/33324051
http://dx.doi.org/10.2147/IJN.S277352

Ejemplares similares